$4.99 0.00 (0%)
12/22/2010 5:00 PM

Clarient, Inc. (NASDAQ:CLRT)

CAPS Rating: 4 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Featured Broker Partners


Advertisement